Pipeline
Pipeline Status
Product                                              Preclinical   |   P1   |   P2   |   P3   |   NDA   |   Marketing
Nodlin
Nodexen
Nodlin
Insulin is the standard treatment for diabetic patients and requires multiple daily injection.

Nodlin is an oral insulin formulation developed by Biolaxy based on NOD technology intended for
basal insulin supplementation.
Nodexen
Exenatide is a first-in-class treatment for diabetes that requires twice daily injections. Nodexen is an
oral exenatide formulation based on encapsulated nano-particles.  This product has the potential to
significantly reduce side effects and improve efficacy over conventional injections.
_____________________________________________________________________________________________________
© All rights reserved.  2005-10  Biolaxy